Validation of Accexible as a Tool for Screening and Monitoring Depression.
Validación Del Sistema de Cribaje y Seguimiento de acceXible Para depresión.
1 other identifier
observational
166
1 country
1
Brief Summary
Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide. A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness. The present study has the objective of validating Accexible as a tool for Screening and Monitoring Depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2023
CompletedFirst Submitted
Initial submission to the registry
July 13, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2025
CompletedMarch 25, 2026
March 1, 2026
1.8 years
July 13, 2023
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of Depression
questionnaire
An average of 1 year
Study Arms (2)
Healthy
Depression
Interventions
Eligibility Criteria
Cases: adults with suspected depression. Controls: healthy controls without depression criteria.
You may qualify if:
- Adult 18-65 years of age.
- Participants must have Spanish as their first language (able to speak and understand verbal messages).
- Participants must have mobile phone with internet.
- Participants must have the ability to understand AcceXible's basic instructions.
- Participants must agree to participate in the study and have voluntarily signed the informed consent.
You may not qualify if:
- To have received a diagnosis of neurodegeneration.
- To have significant vision problems that would affect the ability to perceive visual stimuli.
- To have significant hearing problems that would affect the ability to understand verbal cues.
- To be unable to give informed consent to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Accexiblelead
Study Sites (1)
Vall d'Hebron Institut de Investigación (VHIR)
Barcelona, Barcelona, 08035, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2023
First Posted
September 21, 2023
Study Start
July 10, 2023
Primary Completion
April 17, 2025
Study Completion
April 17, 2025
Last Updated
March 25, 2026
Record last verified: 2026-03